1
|
Albrecht PJ, Liu Y, Houk G, Ruggiero B, Banov D, Dockum M, Day A, Rice FL, Bassani G. Cutaneous targets for topical pain medications in patients with neuropathic pain: individual differential expression of biomarkers supports the need for personalized medicine. Pain Rep 2024; 9:e1119. [PMID: 38375092 PMCID: PMC10876238 DOI: 10.1097/pr9.0000000000001121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Revised: 08/30/2023] [Accepted: 11/07/2023] [Indexed: 02/21/2024] Open
Abstract
Introduction Numerous potential cutaneous targets exist for treating chronic pain with topically applied active pharmaceutical ingredients. This preliminary human skin tissue investigation was undertaken to characterize several key biomarkers in keratinocytes and provide proof-of-principle data to support clinical development of topical compounded formulations for peripheral neuropathic pain syndromes, such as postherpetic neuralgia (PHN). Objectives The study intended to identify objective biomarkers in PHN skin on a patient-by-patient personalized medicine platform. The totality of biopsy biomarker data can provide a tissue basis for directing individualized compounded topical preparations to optimize treatment efficacy. Methods Referencing 5 of the most common actives used in topical pain relief formulations (ketamine, gabapentin, clonidine, baclofen, and lidocaine), and 3 well-established cutaneous mediators (ie, neuropeptides, cannabinoids, and vanilloids), comprehensive immunolabeling was used to quantify receptor biomarkers in skin biopsy samples taken from ipsilateral (pain) and contralateral (nonpain) dermatomes of patients with PHN. Results Epidermal keratinocyte labeling patterns were significantly different among the cohort for each biomarker, consistent with potential mechanisms of action among keratinocytes. Importantly, the total biomarker panel indicates that the enriched PHN cohort contains distinct subgroups. Conclusion The heterogeneity of the cohort differences may explain studies that have not shown statistical group benefit from topically administered compounded therapies. Rather, the essential need for individual tissue biomarker evaluations is evident, particularly as a means to direct a more accurately targeted topical personalized medicine approach and generate positive clinical results.
Collapse
Affiliation(s)
| | - Yi Liu
- Professional Compounding Centers of America (PCCA), Houston, TX, USA
| | - George Houk
- Integrated Tissue Dynamics, LLC (INTiDYN), Rensselaer, NY, USA
| | - Beth Ruggiero
- Integrated Tissue Dynamics, LLC (INTiDYN), Rensselaer, NY, USA
| | - Daniel Banov
- Professional Compounding Centers of America (PCCA), Houston, TX, USA
| | - Marilyn Dockum
- Integrated Tissue Dynamics, LLC (INTiDYN), Rensselaer, NY, USA
| | - A.J. Day
- Professional Compounding Centers of America (PCCA), Houston, TX, USA
| | - Frank L. Rice
- Integrated Tissue Dynamics, LLC (INTiDYN), Rensselaer, NY, USA
| | - Gus Bassani
- Professional Compounding Centers of America (PCCA), Houston, TX, USA
| |
Collapse
|
2
|
Fetell M, Sendel M, Li T, Marinelli L, Vollert J, Ruggerio E, Houk G, Dockum M, Albrecht PJ, Rice FL, Baron R. Cutaneous nerve fiber and peripheral Nav1.7 assessment in a large cohort of patients with postherpetic neuralgia. Pain 2023; 164:2435-2446. [PMID: 37366590 PMCID: PMC10578423 DOI: 10.1097/j.pain.0000000000002950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Revised: 04/06/2023] [Accepted: 04/25/2023] [Indexed: 06/28/2023]
Abstract
ABSTRACT The mechanisms of pain in postherpetic neuralgia (PHN) are still unclear, with some studies showing loss of cutaneous sensory nerve fibers that seemed to correlate with pain level. We report results of skin biopsies and correlations with baseline pain scores, mechanical hyperalgesia, and the Neuropathic Pain Symptom Inventory (NPSI) in 294 patients who participated in a clinical trial of TV-45070, a topical semiselective sodium 1.7 channel (Nav1.7) blocker. Intraepidermal nerve fibers and subepidermal Nav1.7 immunolabeled fibers were quantified in skin punch biopsies from the area of maximal PHN pain, as well as from the contralateral, homologous (mirror image) region. Across the entire study population, a 20% reduction in nerve fibers on the PHN-affected side compared with that in the contralateral side was noted; however, the reduction was much higher in older individuals, approaching 40% in those aged 70 years or older. There was a decrease in contralateral fiber counts as well, also noted in prior biopsy studies, the mechanism of which is not fully clear. Nav1.7-positive immunolabeling was present in approximately one-third of subepidermal nerve fibers and did not differ on the PHN-affected vs contralateral sides. Using cluster analysis, 2 groups could be identified, with the first cluster showing higher baseline pain, higher NPSI scores for squeezing and cold-induced pain, higher nerve fiber density, and higher Nav1.7 expression. While Nav1.7 varies from patient to patient, it does not seem to be a key pathophysiological driver of PHN pain. Individual differences in Nav1.7 expression, however, may determine the intensity and sensory aspects of pain.
Collapse
Affiliation(s)
| | - Manon Sendel
- Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital of Schleswig-Holstein, Campus Kiel, Germany
| | - Thomas Li
- Teva Pharmaceuticals, West Chester, PA, United States
| | | | - Jan Vollert
- Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital of Schleswig-Holstein, Campus Kiel, Germany
- Pain Research, MSk Lab, Department of Surgery and Cancer, Imperial College, London, United Kingdom
- Department of Neurophysiology, Mannheim Center for Translational Neuroscience MCTN, Medical Faculty Mannheim, Ruprecht Karls University, Heidelberg, Germany
- Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, Muenster, Germany
| | | | - George Houk
- Integrated Tissue Dynamics LLC, Rensselaer, NY, United States
| | - Marilyn Dockum
- Integrated Tissue Dynamics LLC, Rensselaer, NY, United States
| | | | - Frank L. Rice
- Integrated Tissue Dynamics LLC, Rensselaer, NY, United States
| | - Ralf Baron
- Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital of Schleswig-Holstein, Campus Kiel, Germany
| |
Collapse
|
3
|
Lin X, Xu Z, Carey L, Romero J, Makriyannis A, Hillard CJ, Ruggiero E, Dockum M, Houk G, Mackie K, Albrecht PJ, Rice FL, Hohmann AG. A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse. Pain 2022; 163:834-851. [PMID: 35001054 PMCID: PMC8942871 DOI: 10.1097/j.pain.0000000000002502] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2021] [Revised: 09/13/2021] [Accepted: 09/15/2021] [Indexed: 01/10/2023]
Abstract
ABSTRACT CB2 cannabinoid receptors (CB2) are a promising therapeutic target that lacks unwanted side effects of CB1 activation. However, the cell types expressing CB2 that mediate these effects remain poorly understood. We used transgenic mice with CB2 promoter-driven expression of enhanced green fluorescent protein (EGFP) to study cell types that express CB2 and suppress neuropathic nociception in a mouse model of chemotherapy-induced peripheral neuropathy. Structurally distinct CB2 agonists (AM1710 and LY2828360) suppressed paclitaxel-induced mechanical and cold allodynia in CB2EGFP reporter mice with established neuropathy. Antiallodynic effects of AM1710 were blocked by SR144528, a CB2 antagonist with limited CNS penetration. Intraplantar AM1710 administration suppressed paclitaxel-induced neuropathic nociception in CB2EGFP but not CB2 knockout mice, consistent with a local site of antiallodynic action. mRNA expression levels of the anti-inflammatory cytokine interleukin-10 were elevated in the lumbar spinal cord after intraplantar AM1710 injection along with the proinflammatory cytokine tumor necrosis factor alpha and chemokine monocyte chemoattractant protein-1. CB2EGFP, but not wildtype mice, exhibited anti-GFP immunoreactivity in the spleen. However, the anti-GFP signal was below the threshold for detection in the spinal cord and brain of either vehicle-treated or paclitaxel-treated CB2EGFP mice. EGFP fluorescence was coexpressed with CB2 immunolabeling in stratified patterns among epidermal keratinocytes. EGFP fluorescence was also expressed in dendritic cells in the dermis, Langerhans cells in the epidermis, and Merkel cells. Quantification of the EGFP signal revealed that Langerhans cells were dynamically increased in the epidermis after paclitaxel treatment. Our studies implicate CB2 expressed in previously unrecognized populations of skin cells as a potential target for suppressing chemotherapy-induced neuropathic nociception.
Collapse
Affiliation(s)
- Xiaoyan Lin
- Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States
| | - Zhili Xu
- Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States
| | - Lawrence Carey
- Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States
- Program in Neuroscience, Indiana University, Bloomington, IN, United States
| | - Julian Romero
- Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Madrid, Spain
| | - Alexandros Makriyannis
- School of Pharmacy, Bouvé College of Health Sciences, Center for Drug Discovery, College of Science, Health Sciences Entrepreneurs, Northeastern University, Boston, MA, United States
| | - Cecilia J. Hillard
- Department of Pharmacology and Toxicology, Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI, United States
| | | | - Marilyn Dockum
- Integrated Tissue Dynamics LLC, Rensselaer, NY, United States
| | - George Houk
- Integrated Tissue Dynamics LLC, Rensselaer, NY, United States
| | - Ken Mackie
- Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States
- Program in Neuroscience, Indiana University, Bloomington, IN, United States
- Gill Center for Biomolecular Science, Indiana University, Bloomington, IN, United States
| | | | - Frank L. Rice
- Integrated Tissue Dynamics LLC, Rensselaer, NY, United States
| | - Andrea G. Hohmann
- Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States
- Program in Neuroscience, Indiana University, Bloomington, IN, United States
- Gill Center for Biomolecular Science, Indiana University, Bloomington, IN, United States
| |
Collapse
|
4
|
Albrecht PJ, Houk G, Ruggiero E, Dockum M, Czerwinski M, Betts J, Wymer JP, Argoff CE, Rice FL. Keratinocyte Biomarkers Distinguish Painful Diabetic Peripheral Neuropathy Patients and Correlate With Topical Lidocaine Responsiveness. Front Pain Res 2021; 2:790524. [PMID: 35295428 PMCID: PMC8915676 DOI: 10.3389/fpain.2021.790524] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Accepted: 11/03/2021] [Indexed: 01/11/2023] Open
Abstract
This study investigated quantifiable measures of cutaneous innervation and algesic keratinocyte biomarkers to determine correlations with clinical measures of patient pain perception, with the intent to better discriminate between diabetic patients with painful diabetic peripheral neuropathy (PDPN) compared to patients with low-pain diabetic peripheral neuropathy (lpDPN) or healthy control subjects. A secondary objective was to determine if topical treatment with a 5% lidocaine patch resulted in correlative changes among the quantifiable biomarkers and clinical measures of pain perception, indicative of potential PDPN pain relief. This open-label proof-of-principle clinical research study consisted of a pre-treatment skin biopsy, a 4-week topical 5% lidocaine patch treatment regimen for all patients and controls, and a post-treatment skin biopsy. Clinical measures of pain and functional interference were used to monitor patient symptoms and response for correlation with quantitative skin biopsy biomarkers of innervation (PGP9.5 and CGRP), and epidermal keratinocyte biomarkers (Nav1.6, Nav1.7, CGRP). Importantly, comparable significant losses of epidermal neural innervation (intraepidermal nerve fibers; IENF) and dermal innervation were observed among PDPN and lpDPN patients compared with control subjects, indicating that innervation loss alone may not be the driver of pain in diabetic neuropathy. In pre-treatment biopsies, keratinocyte Nav1.6, Nav1.7, and CGRP immunolabeling were all significantly increased among PDPN patients compared with control subjects. Importantly, no keratinocyte biomarkers were significantly increased among the lpDPN group compared with control. In post-treatment biopsies, the keratinocyte Nav1.6, Nav1.7, and CGRP immunolabeling intensities were no longer different between control, lpDPN, or PDPN cohorts, indicating that lidocaine treatment modified the PDPN-related keratinocyte increases. Analysis of the PDPN responder population demonstrated that increased pretreatment keratinocyte biomarker immunolabeling for Nav1.6, Nav1.7, and CGRP correlated with positive outcomes to topical lidocaine treatment. Epidermal keratinocytes modulate the signaling of IENF, and several analgesic and algesic signaling systems have been identified. These results further implicate epidermal signaling mechanisms as modulators of neuropathic pain conditions, highlight a novel potential mode of action for topical treatments, and demonstrate the utility of comprehensive skin biopsy evaluation to identify novel biomarkers in clinical pain studies.
Collapse
Affiliation(s)
- Phillip J. Albrecht
- Neuroscience and Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY, United States
- Division of Health Sciences, University at Albany, Albany, NY, United States
- *Correspondence: Phillip J. Albrecht
| | - George Houk
- Neuroscience and Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY, United States
| | - Elizabeth Ruggiero
- Neuroscience and Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY, United States
| | - Marilyn Dockum
- Neuroscience and Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY, United States
| | | | - Joseph Betts
- Neuroscience and Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY, United States
| | - James P. Wymer
- Department of Neurology, University of Florida College of Medicine, Gainesville, FL, United States
| | - Charles E. Argoff
- Department of Neurology, Albany Medical Center, Albany, NY, United States
| | - Frank L. Rice
- Neuroscience and Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY, United States
- Division of Health Sciences, University at Albany, Albany, NY, United States
| |
Collapse
|
5
|
Rice FL, Castel D, Ruggiero E, Dockum M, Houk G, Sabbag I, Albrecht PJ, Meilin S. Human-like cutaneous neuropathologies associated with a porcine model of peripheral neuritis: A translational platform for neuropathic pain. Neurobiol Pain 2019; 5:100021. [PMID: 31194066 PMCID: PMC6550106 DOI: 10.1016/j.ynpai.2018.07.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/29/2018] [Revised: 07/19/2018] [Accepted: 07/19/2018] [Indexed: 01/10/2023]
Abstract
Despite enormous investment in research and development of novel treatments, there remains a lack of predictable, effective, and safe therapeutics for human chronic neuropathic pain (NP) afflictions. NP continues to increase among the population and treatments remain a major unmet public health care need. In recent years, numerous costly (time and money) failures have occurred attempting to translate successful animal pain model results, typically using rodents, to human clinical trials. These continued failures point to the essential need for better animal models of human pain conditions. To address this challenge, we have previously developed a peripheral neuritis trauma (PNT) model of chronic pain induced by a proximal sciatic nerve irritation in pigs, which have a body size, metabolism, skin structure, and cutaneous innervation more similar to humans. Here, we set out to determine the extent that the PNT model presents with cutaneous neuropathologies consistent with those associated with human chronic NP afflictions. Exactly as is performed in human skin biopsies, extensive quantitative multi-molecular immunofluorescence analyses of porcine skin biopsies were performed to assess cutaneous innervation and skin structure. ChemoMorphometric Analysis (CMA) results demonstrated a significant reduction in small caliber intraepidermal nerve fiber (IENF) innervation, altered dermal vascular innervation, and aberrant analgesic/algesic neurochemical properties among epidermal keratinocytes, which are implicated in modulating sensory innervation. These comprehensive pathologic changes very closely resemble those observed from CMA of human skin biopsies collected from NP afflictions. The results indicate that the porcine PNT model is more appropriate for translational NP research compared with commonly utilized rodent models. Because the PNT model creates cutaneous innervation and keratinocyte immunolabeling alterations consistent with human NP conditions, use of this animal model for NP testing and treatment response characteristics will likely provide more realistic results to direct successful translation to humans.
Collapse
Affiliation(s)
- Frank L. Rice
- Neuroscience & Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY 12144, United States
- Division of Health Sciences, University at Albany, Rensselaer, NY 12144, United States
| | - David Castel
- The Neufeld Cardiac Research Institute, Sheba Medical Centre, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel
| | - Elizabeth Ruggiero
- Neuroscience & Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY 12144, United States
| | - Marilyn Dockum
- Neuroscience & Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY 12144, United States
| | - George Houk
- Neuroscience & Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY 12144, United States
| | - Itai Sabbag
- Lahav Research Institute, Kibutz Lahav, Negev 85335, Israel
| | - Phillip J. Albrecht
- Neuroscience & Pain Research Group, Integrated Tissue Dynamics, LLC, Rensselaer, NY 12144, United States
- Division of Health Sciences, University at Albany, Rensselaer, NY 12144, United States
| | - Sigal Meilin
- MD Biosciences, Neurology R&D Division, Nes-Ziona 74140, Israel
| |
Collapse
|
6
|
Abe F, Albrow MG, Amendolia SR, Amidei D, Antos J, Anway-Wiese C, Apollinari G, Areti H, Atac M, Auchincloss P, Azfar F, Azzi P, Bacchetta N, Badgett W, Bailey MW, Bao J, de Barbaro P, Barbaro-Galtieri A, Barnes VE, Barnett BA, Bartalini P, Bauer G, Baumann T, Bedeschi F, Behrends S, Belforte S, Bellettin G, Bellinger J, Benjamin D, Benlloch J, Bensinger J, Benton D, Beretvas A, Berge JP, Bertolucci S, Bhatti A, Biery K, Binkley M, Bird F, Bisello D, Blair RE, Blocker C, Bodek A, Bokhari W, Bolognesi V, Bortoletto D, Boswell C, Boulos T, Brandenburg G, Bromberg C, Buckley-Geer E, Budd HS, Burkett K, Busetto G, Byon-Wagner A, Byrum KL, Cammerata J, Campagnari C, Campbell M, Caner A, Carithers W, Carlsmith D, Castro A, Cen Y, Cervelli F, Chao HY, Chapman J, Cheng MT, Chiarelli G, Chikamatsu T, Chiou CN, Christofek L, Cihangir S, Clark AG, Cobal M, Contreras M, Conway J, Cooper J, Cordelli M, Couyoumtzelis C, Crane D, Cunningham JD, Daniels T, DeJongh F, Delchamps S, Dell’Agnello S, Dell’Orso M, Demortier L, Denby B, Deninno M, Derwent PF, Devlin T, Dickson M, Dittmann JR, Donati S, Drucker RB, Dunn A, Einsweiler K, Elias JE, Ely R, Engels E, Eno S, Errede D, Errede S, Fan Q, Farhat B, Fiori I, Flaugher B, Foster GW, Franklin M, Frautschi M, Freeman J, Friedman J, Frisch H, Fry A, Fuess TA, Fukui Y, Funaki S, Gagliardi G, Galeotti S, Gallinaro M, Garfinkel AF, Geer S, Gerdes DW, Giannetti P, Giokaris N, Giromini P, Gladney L, Glenzinski D, Gold M, Gonzalez J, Gordon A, Goshaw AT, Goulianos K, Grassmann H, Grewal A, Groer L, Grosso-Pilcher C, Haber C, Hahn SR, Hamilton R, Handler R, Hans RM, Hara K, Harral B, Harris RM, Hauger SA, Hauser J, Hawk C, Heinrich J, Cronin-Hennessy D, Hollebeek R, Holloway L, Hölscher A, Hong S, Houk G, Hu P, Huffman BT, Hughes R, Hurst P, Huston J, Huth J, Hylen J, Incagli M, Incandela J, Iso H, Jensen H, Jessop CP, Joshi U, Kadel RW, Kajfasz E, Kamon T, Kaneko T, Kardelis DA, Kasha H, Kato Y, Keeble L, Kennedy RD, Kephart R, Kesten P, Kestenbaum D, Keup RM, Keutelian H, Keyvan F, Kim DH, Kim HS, Kim SB, Kim SH, Kim YK, Kirsch L, Koehn P, Kondo K, Konigsberg J, Kopp S, Kordas K, Koska W, Kovacs E, Kowald W, Krasberg M, Kroll J, Kruse M, Kuhlmann SE, Kuns E, Laasanen AT, Labanca N, Lammel S, Lamoureux JI, LeCompte T, Leone S, Lewis JD, Limon P, Lindgren M, Liss TM, Lockyer N, Loomis C, Long O, Loreti M, Low EH, Lu J, Lucchesi D, Luchini CB, Lukens P, Lys J, Maas P, Maeshima K, Maghakian A, Maksimovic P, Mangano M, Mansour J, Mariotti M, Marriner JP, Martin A, Matthews JAJ, Mattingly R, McIntyre P, Melese P, Menzione A, Meschi E, Michail G, Mikamo S, Miller M, Miller R, Mimashi T, Miscetti S, Mishina M, Mitsushio H, Miyashita S, Morita Y, Moulding S, Mueller J, Mukherjee A, Muller T, Musgrave P, Nakae LF, Nakano I, Nelson C, Neuberger D, Newman-Holmes C, Nodulman L, Ogawa S, Oh SH, Ohl KE, Oishi R, Okusawa T, Pagliarone C, Paoletti R, Papadimitriou V, Pappas SP, Park S, Patrick J, Pauletta G, Paulini M, Pescara L, Peters MD, Phillips TJ, Piacentino G, Pillai M, Plunkett R, Pondrom L, Produit N, Proudfoot J, Ptohos F, Punzi G, Ragan K, Rimondi F, Ristori L, Roach-Bellino M, Robertson WJ, Rodrigo T, Romano J, Rosenson L, Sakumoto WK, Saltzberg D, Sansoni A, Scarpine V, Schindler A, Schlabach P, Schmidt EE, Schmidt MP, Schneider O, Sciacca GF, Scribano A, Segler S, Seidel S, Seiya Y, Sganos G, Sgolacchia A, Shapiro M, Shaw NM, Shen Q, Shepard PF, Shimojima M, Shochet M, Siegrist J, Sill A, Sinervo P, Singh P, Skarha J, Sliwa K, Smith DA, Snider FD, Song L, Song T, Spalding J, Spiegel L, Sphicas P, Stanco L, Steele J, Stefanini A, Strahl K, Strait J, Stuart D, Sullivan G, Sumorok K, Swartz RL, Takahashi T, Takikawa K, Tartarelli F, Taylor W, Teng PK, Teramoto Y, Tether S, Theriot D, Thomas J, Thomas TL, Thun R, Timko M, Tipton P, Titov A, Tkaczyk S, Tollefson K, Tollestrup A, Tonnison J, de Troconiz JF, Tseng J, Turcotte M, Turini N, Uemura N, Ukegawa F, Unal G, van den Brink SC, Vejcik S, Vidal R, Vondracek M, Vucinic D, Wagner RG, Wagner RL, Wainer N, Walker RC, Wang C, Wang CH, Wang G, Wang J, Wang MJ, Wang QF, Warburton A, Watts G, Watts T, Webb R, Wei C, Wendt C, Wenzel H, Wester WC, Westhusing T, Wicklund AB, Wicklund E, Wilkinson R, Williams HH, Wilson P, Winer BL, Wolinski J, Wu DY, Wu X, Wyss J, Yagil A, Yao W, Yasuoka K, Ye Y, Yeh GP, Yeh P, Yin M, Yoh J, Yosef C, Yoshida T, Yovanovitch D, Yu I, Yun JC, Zanetti A, Zetti F, Zhang L, Zhang S, Zhang W, Zucchelli S. Measurement of the associatedγ+μ±production cross section inpp¯collisions ats=1.8TeV. Int J Clin Exp Med 1999. [DOI: 10.1103/physrevd.60.092003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
7
|
Abe F, Albrow MG, Amendolia SR, Amidei D, Antos J, Anway-Wiese C, Apollinari G, Areti H, Atac M, Auchincloss P, Azfar F, Azzi P, Bacchetta N, Badgett W, Bailey MW, Bao J, de Barbaro P, Barbaro-Galtieri A, Barnes VE, Barnett BA, Bartalini P, Bauer G, Baumann T, Bedeschi F, Behrends S, Belforte S, Bellettini G, Bellinger J, Benjamin D, Benlloch J, Bensinger J, Benton D, Beretvas A, Berge JP, Bertolucci S, Bhatti A, Biery K, Binkley M, Bird F, Bisello D, Blair RE, Blocker C, Bodek A, Bokhari W, Bolognesi V, Bortoletto D, Boswell C, Boulos T, Brandenburg G, Bromberg C, Buckley-Geer E, Budd HS, Burkett K, Busetto G, Byon-Wagner A, Byrum KL, Cammerata J, Campagnari C, Campbell M, Caner A, Carithers W, Carlsmith D, Castro A, Cen Y, Cervelli F, Chao HY, Chapman J, Cheng MT, Chiarelli G, Chikamatsu T, Chiou CN, Christofek L, Cihangir S, Clark AG, Cobal M, Contreras M, Conway J, Cooper J, Cordelli M, Couyoumtzelis C, Crane D, Cunningham JD, Daniels T, DeJongh F, Delchamps S, Dell’Agnello S, Dell’Orso M, Demortier L, Denby B, Deninno M, Derwent PF, Devlin T, Dickson M, Dittmann JR, Donati S, Drucker RB, Dunn A, Einsweiler K, Elias JE, Ely R, Engels E, Eno S, Errede D, Errede S, Fan Q, Farhat B, Fiori I, Flaugher B, Foster GW, Franklin M, Frautschi M, Freeman J, Friedman J, Frisch H, Fry A, Fuess TA, Fukui Y, Funaki S, Gagliardi G, Galeotti S, Gallinaro M, Garfinkel AF, Geer S, Gerdes DW, Giannetti P, Giokaris N, Giromini P, Gladney L, Glenzinski D, Gold M, Gonzalez J, Gordon A, Goshaw AT, Goulianos K, Grassmann H, Grewal A, Groer L, Grosso-Pilcher C, Haber C, Hahn SR, Hamilton R, Handler R, Hans RM, Hara K, Harral B, Harris RM, Hauger SA, Hauser J, Hawk C, Heinrich J, Cronin-Hennessy D, Hollebeek R, Holloway L, Hölscher A, Hong S, Houk G, Hu P, Huffman BT, Hughes R, Hurst P, Huston J, Huth J, Hylen J, Incagli M, Incandela J, Iso H, Jensen H, Jessop CP, Joshi U, Kadel RW, Kajfasz E, Kamon T, Kaneko T, Kardelis DA, Kasha H, Kato Y, Keeble L, Kennedy RD, Kephart R, Kesten P, Kestenbaum D, Keup RM, Keutelian H, Keyvan F, Kim DH, Kim HS, Kim SB, Kim SH, Kim YK, Kirsch L, Koehn P, Kondo K, Konigsberg J, Kopp S, Kordas K, Koska W, Kovacs E, Kowald W, Krasberg M, Kroll J, Kruse M, Kuhlmann SE, Kuns E, Laasanen AT, Labanca N, Lammel S, Lamoureux JI, LeCompte T, Leone S, Lewis JD, Limon P, Lindgren M, Liss TM, Lockyer N, Loomis C, Long O, Loreti M, Low EH, Lu J, Lucchesi D, Luchini CB, Lukens P, Lys J, Maas P, Maeshima K, Maghakian A, Maksimovic P, Mangano M, Mansour J, Mariotti M, Marriner JP, Martin A, Matthews JAJ, Mattingly R, McIntyre P, Melese P, Menzione A, Meschi E, Michail G, Mikamo S, Miller M, Miller R, Mimashi T, Miscetti S, Mishina M, Mitsushio H, Miyashita S, Morita Y, Moulding S, Mueller J, Mukherjee A, Muller T, Musgrave P, Nakae LF, Nakano I, Nelson C, Neuberger D, Newman-Holmes C, Nodulman L, Ogawa S, Oh SH, Ohl KE, Oishi R, Okusawa T, Pagliarone C, Paoletti R, Papadimitriou V, Pappas SP, Park S, Patrick J, Pauletta G, Paulini M, Pescara L, Peters MD, Phillips TJ, Piacentino G, Pillai M, Plunkett R, Pondrom L, Produit N, Proudfoot J, Ptohos F, Punzi G, Ragan K, Rimondi F, Ristori L, Roach-Bellino M, Robertson WJ, Rodrigo T, Romano J, Rosenson L, Sakumoto WK, Saltzberg D, Sansoni A, Scarpine V, Schindler A, Schlabach P, Schmidt EE, Schmidt MP, Schneider O, Sciacca GF, Scribano A, Segler S, Seidel S, Seiya Y, Sganos G, Sgolacchia A, Shapiro M, Shaw NM, Shen Q, Shepard PF, Shimojima M, Shochet M, Siegrist J, Sill A, Sinervo P, Singh P, Skarha J, Sliwa K, Smith DA, Snider FD, Song L, Song T, Spalding J, Spiegel L, Sphicas P, Stanco L, Steele J, Stefanini A, Strahl K, Strait J, Stuart D, Sullivan G, Sumorok K, Swartz RL, Takahashi T, Takikawa K, Tartarelli F, Taylor W, Teng PK, Teramoto Y, Tether S, Theriot D, Thomas J, Thomas TL, Thun R, Timko M, Tipton P, Titov A, Tkaczyk S, Tollefson K, Tollestrup A, Tonnison J, de Troconiz JF, Tseng J, Turcotte M, Turini N, Uemura N, Ukegawa F, Unal G, van den Brink SC, Vejcik S, Vidal R, Vondracek M, Vucinic D, Wagner RG, Wagner RL, Wainer N, Walker RC, Wang C, Wang CH, Wang G, Wang J, Wang MJ, Wang QF, Warburton A, Watts G, Watts T, Webb R, Wei C, Wendt C, Wenzel H, Wester WC, Westhusing T, Wicklund AB, Wicklund E, Wilkinson R, Williams HH, Wilson P, Winer BL, Wolinski J, Wu DY, Wu X, Wyss J, Yagil A, Yao W, Yasuoka K, Ye Y, Yeh GP, Yeh P, Yin M, Yoh J, Yosef C, Yoshida T, Yovanovitch D, Yu I, Yun JC, Zanetti A, Zetti F, Zhang L, Zhang S, Zhang W, Zucchelli S. Jet pseudorapidity distribution in direct photon events inpp¯collisions ats=1.8TeV. Int J Clin Exp Med 1998. [DOI: 10.1103/physrevd.57.1359] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
8
|
Abe F, Albrow M, Amidei D, Anway-Wiese C, Apollinari G, Atac M, Auchincloss P, Azzi P, Baden AR, Bacchetta N, Badgett W, Bailey MW, Bamberger A, de Barbaro P, Barbaro-Galtieri A, Barnes VE, Barnett BA, Bauer G, Baumann T, Bedeschi F, Behrends S, Belforte S, Bellettini G, Bellinger J, Benjamin D, Benlloch J, Bensinger J, Beretvas A, Berge JP, Bertolucci S, Biery K, Bhadra S, Binkley M, Bisello D, Blair R, Blocker C, Bodek A, Bolognesi V, Booth AW, Boswell C, Brandenburg G, Brown D, Buckley-Geer E, Budd HS, Busetto G, Byon-Wagner A, Byrum KL, Campagnari C, Campbell M, Caner A, Carey R, Carithers W, Carlsmith D, Carroll JT, Cashmore R, Castro A, Cervelli F, Chadwick K, Chapman J, Chiarelli G, Chinowsky W, Cihangir S, Clark AG, Cobal M, Connor D, Contreras M, Cooper J, Cordelli M, Crane D, Cunningham JD, Day C, DeJongh F, Dell'Agnello S, Dell'Orso M, Demortier L, Denby B, Derwent PF, Devlin T, DiBitonto D, Dickson M, Drucker RB, Einsweiler K, Elias JE, Ely R, Eno S, Errede S, Etchegoyen A, Farhat B, Frautschi M, Feldman GJ, Flaugher B, Foster GW, Franklin M, Freeman J, Frisch H, Fuess T, Fukui Y, Garfinkel AF, Gauthier A, Geer S, Gerdes DW, Giannetti P, Giokaris N, Giromini P, Gladney L, Gold M, Gonzalez J, Goulianos K, Grassmann H, Grieco GM, Grindley R, Grosso-Pilcher C, Haber C, Hahn SR, Handler R, Hara K, Harral B, Harris RM, Hauger SA, Hauser J, Hawk C, Hessing T, Hollebeek R, Hölscher A, Hong S, Houk G, Hu P, Hubbard B, Huffman BT, Hughes R, Hurst P, Huth J, Hylen J, Incagli M, Ino T, Jensen H, Jessop CP, Johnson RP, Joshi U, Kadel RW, Kamon T, Kanda S, Kardelis DA, Karliner I, Kearns E, Keeble L, Kephart R, Kesten P, Keup RM, Keutelian H, Kim D, Kim SB, Kim SH, Kim YK, Kirsch L, Kondo K, Konigsberg J, Kordas K, Kovacs E, Krasberg M, Kuhlmann SE, Kuns E, Laasanen AT, Lammel S, Lamoureux JI, Leone S, Lewis JD, Li W, Limon P, Lindgren M, Liss TM, Lockyer N, Loreti M, Low EH, Lucchesi D, Luchini CB, Lukens P, Maas P, Maeshima K, Mangano M, Marriner JP, Mariotti M, Markeloff R, Markosky LA, Matthews J, Mattingly R, McIntyre P, Menzione A, Meschi E, Meyer T, Mikamo S, Miller M, Mimashi T, Miscetti S, Mishina M, Miyashita S, Morita Y, Moulding S, Mueller J, Mukherjee A, Muller T, Nakae LF, Nakano I, Nelson C, Neuberger D, Newman-Holmes C, Ng JST, Ninomiya M, Nodulman L, Ogawa S, Paoletti R, Papadimitriou V, Para A, Pare E, Park S, Patrick J, Pauletta G, Pescara L, Piacentino G, Phillips TJ, Ptohos F, Plunkett R, Pondrom L, Proudfoot J, Punzi G, Quarrie D, Ragan K, Redlinger G, Rhoades J, Roach M, Rimondi F, Ristori L, Robertson WJ, Rodrigo T, Rohaly T, Roodman A, Sakumoto WK, Sansoni A, Sard RD, Savoy-Navarro A, Scarpine V, Schlabach P, Schmidt EE, Schneider O, Schub MH, Schwitters R, Sciacca G, Scribano A, Segler S, Seidel S, Seiya Y, Sganos G, Shapiro M, Shaw NM, Sheaff M, Shochet M, Siegrist J, Sill A, Sinervo P, Skarha J, Sliwa K, Smith DA, Snider FD, Song L, Song T, Spahn M, Spies A, Sphicas P, Denis RS, Stanco L, Stefanini A, Sullivan G, Sumorok K, Swartz RL, Takano M, Takikawa K, Tarem S, Tartarelli F, Tether S, Theriot D, Timko M, Tipton P, Tkaczyk S, Tollestrup A, Tonnison J, Trischuk W, Tsay Y, Tseng J, Turini N, Ukegawa F, Underwood D, Vejcik S, Vidal R, Wagner RG, Wagner RL, Wainer N, Walker RC, Walsh J, Watts G, Watts T, Webb R, Wendt C, Wenzel H, Wester WC, Westhusing T, White SN, Wicklund AB, Wicklund E, Williams HH, Winer BL, Wolinski J, Wu DY, Wu X, Wyss J, Yagil A, Yasuoka K, Ye Y, Yeh GP, Yi C, Yoh J, Yokoyama M, Yun JC, Zanetti A, Zetti F, Zhang S, Zhang W, Zucchelli S. Measurement of the dijet mass distribution in pp-bar collisions at sqrt s =1.8 TeV. Phys Rev D Part Fields 1993; 48:998-1008. [PMID: 10016336 DOI: 10.1103/physrevd.48.998] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|